Benjamin Shobert
- Part-time Lecturer of Management and Organization
Professional Certification
MBA
Education
- MBA Duke University (2009)
- BS Indiana University (1998)
Academic Expertise
- strategic planning
Positions Held
- At the University of Washington since 2017
- Managing Director, Rubicon Strategy Group, 2012-present
Selected Publications
“Designing Profitable Partnerships with Chinese Hospitals”
Shobert, B., and Huang, J., (2016). China Business Review.
“The Rise of Chinese Innovation in the Life Sciences”
Shobert, B., Wong, J., and Fei, X., (2016). National Bureau of Asian Research.
“The Future of Pharmaceutical Marketing in China”
Shobert, B., and Huang, J., (2016). Rubicon Strategy Group.
“China’s Senior Care Industry”
Shobert, B., Qu, Q., Christian, J., DeNoble, D., and Yan, Y., (2015). Rubicon Strategy Group.
“Mixed Prognosis”
Shobert, B., (2014). China Hands, Yale University.
“USCC Hearing: China’s Healthcare Sector, Drug Safety, and the U.S.–China Trade in Medical Products”
Shobert, B., (2014). U.S.–China Economic and Security Review Commission.
“Understanding China’s Antimonopoly (AML) Investigations”
Shobert, B., and DeNoble, D., (2014). China Business Review.
“How Should Foreign Companies Interpret GSK’s China Fines and Penalties?”
Shobert, B., (2014). Forbes.
“China’s Energy Crossroads: Forging a New Energy and Environmental Balance”
Shobert, B., Andrews-Speed, P., Herberg, M., Zhidong, L., Miller, M., and Gillispie, C., (2014). The National Bureau of Asian Research.
“China’s Healthcare Reforms – The Promise and the Peril”
Shobert, B., (2013). Harvard Asia Quarterly.
“Why Glaxo’s China Scandal Needed to Happen”
Shobert, B., (2013). CNBC.
“Disruptive Forces in the Global Life Sciences Sector”
Shobert, B., and Topal, C., (2013).
“Bank On It: Is This Volunteer Program the Solution to China’s Elder-Care Crisis?”
Shobert, B., (2013). Slate.
“The Global Obama: Crossroads of Leadership in the 21st Century”
Shobert, B., (2013). Routledge Publishing.
Courses Taught
- MGMT 579 - The Globalization of Healthcare Services & the Biotech Industry